Clinical Trial

Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 24, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi. The advent of tubeless PCNL (without indwelling nephrostomy tube) has been proved to be safe and effective in reducing postoperative discomfort, shortening hospitalization time and reducing hospitalization costs. Traditional tubeless PCNL usually involves retrograde insertion of the ureteral catheter, which may cause many ureteral related surgical complications. However, there are few reports on tubeless PCNL without reverse ureteral catheter insertion. The goal of this study is to explore the safety and effectiveness of the tubeless PCNL without reverse ureteral catheter insertion.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-10-07; most recent amendment 2024-09-23.
Trial Details
NCT Number NCT05574517
Lead Sponsor The First Affiliated Hospital of University of South China
Conditions Urinary Calculi, Percutaneous Nephrolithotomy
Enrollment 200 participants
Start Date 2022-10-07
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-24